Home › Funds › TANG CAPITAL MANAGEMENT LLC › NUVB

TANG CAPITAL MANAGEMENT LLC position in NUVB

NUVATION BIO INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 3,299,557 shares of NUVB (NUVATION BIO INC) in its Q2 2026 13F filing — a position valued at US$18.7M, representing 0.85% of its reported portfolio and ranking #27 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)3.30M sh
Reported value held$18.74M
Portfolio Weight0.85%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's NUVB position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in NUVB in Q4 2023 at 3,500,000 shares (US$5.3M). The position peaked in Q4 2025 at 3,857,457 shares, worth US$34.6M. Across 11 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 3,299,557 shares valued at US$18.7M — an increase of 150,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.50M $5.29M New
Q1 2024 3.55M $12.93M Add
Q2 2024 3.75M $10.96M Add
Q3 2024 3.90M $8.93M Add
Q4 2024 3.90M $10.37M Hold
Q1 2025 3.90M $6.86M Hold
Q2 2025 3.90M $7.61M Hold
Q3 2025 4.20M $15.54M Add
Q4 2025 3.86M $34.56M Reduce
Q1 2026 3.15M $13.51M Reduce
Q2 2026 3.30M $18.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 53 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held NUVB?

TANG CAPITAL MANAGEMENT LLC has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in NUVB?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 3.30M shares of NUVB (NUVATION BIO INC), valued at $18.74M, representing 0.85% of its reported portfolio and ranking #27.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling NUVB?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC increased its position in NUVB. The position peaked in Q4 2025 at 3.86M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.